Written by Dr. Diane Mueller
You’ve probably seen it by now.
Someone in a Lyme Facebook group posts about finally turning a corner after years of treatment… and buried in the comments is the word that starts a whole new rabbit hole:
“Have you tried dapsone?”
Next thing you know, you’re up late, blue light blasting your eyeballs, Googling dapsone Lyme disease, scrolling through case reports, protocols, and long, emotional threads.
Some people say it changed everything.
Others say it wrecked their health.
If you’re feeling a mix of hope, fear, and “I don’t want to miss my chance,” you’re not alone.
What you actually want isn’t another hype train.
You want clarity.
Why are so many patients suddenly talking about dapsone?
What does it actually do in the body?
Does it really get at “persister” forms of Borrelia… or is that oversold online?
And maybe the most important question: how do you know whether it makes sense for you?
Let’s walk through what’s actually known, where dapsone can sometimes help, where it falls short, and what to ask your Lyme-literate provider before you even think about picking up a prescription.
Dapsone Lyme disease protocols target so‑called persister forms of Borrelia. Still, the evidence is early, mixed, and based largely on lab studies and small case series rather than large clinical trials.
Dapsone is an older sulfa antibiotic originally approved for leprosy and certain skin disorders, now used off‑label in select chronic Lyme cases after other well‑designed treatments have provided only partial or temporary relief.
While some patients report meaningful short‑term improvements on dapsone Lyme disease regimens, relapse within 6–12 months is common if root issues like mold exposure, coinfections, immune dysregulation, and toxin burden are not addressed.
Dapsone carries serious risks—including hemolytic anemia, methemoglobinemia, liver stress, and potentially life‑threatening skin reactions—so G6PD screening, frequent lab monitoring, and close supervision by a Lyme‑literate clinician are essential.
Alternatives and complements to dapsone include herbal antimicrobials, biofilm strategies, detox and mitochondrial support, nervous system regulation, and broader functional medicine work, all of which should be part of a comprehensive, individualized Lyme treatment plan.
Dapsone is not a new, exotic Lyme drug.
It’s actually an old antibiotic from a completely different world of medicine.
Dapsone was originally used for:
Leprosy (Hansen’s disease)
Certain severe skin conditions, like dermatitis herpetiformis (often linked with celiac disease)
Some immune-related blistering diseases
It works mainly by interfering with folate metabolism in bacteria, which slows their growth. It’s in the “sulfonamide” family (sulfa-type drugs), so it carries many of the risks and sensitivities that group is known for.
So how did a leprosy drug end up in chronic Lyme conversations?
Researchers started looking at persister forms of Borrelia (and other microbes) that seemed resistant to standard antibiotics. In lab studies, dapsone showed activity against some of these forms when combined with other drugs.
A few Lyme-literate clinicians began using dapsone off-label, meaning for a condition it’s not FDA-approved to treat, based on:
In vitro (test-tube) data on persisters
Theoretical mechanisms
Early case series that suggested some patients improved when dapsone was added to a protocol.
Because many chronic Lyme patients are already treatment-experienced and exhausted, dapsone often shows up as a “last resort” antibiotic, the thing people reach for after they’ve “tried everything.”
Off-label doesn’t automatically mean unsafe or wrong.
So many functional and integrative strategies technically fall into that category.
But off-label does mean:
The evidence is more limited or early-stage.
There may not be large, controlled trials for your exact situation.
You’re relying heavily on your provider’s clinical judgment, and your own comfort with risk.
This is where a careful conversation with a Lyme-literate practitioner, like those at My Lyme Doc, becomes critical. You need someone who understands not just the drug, but your whole terrain: infections, mold, autoimmunity, hormones, refresh capacity, and nervous system health.
To understand why dapsone got popular, you need a quick tour of persister biology, without falling asleep.
Think of Borrelia (the main Lyme organism) like a city of shape‑shifters.
Some are:
Active, fast-growing forms that most antibiotics easily target.
Others slow down, go dormant, hide in biofilms (slimy protective communities), or change shape.
These “low‑metabolism,” persister, or dormant cells are harder to kill because many antibiotics work best on actively dividing bacteria.
So you might nuke the busy forms, feel suitable for a while… but the quiet ones in the shadows remain. When treatment stops, and your immune system is still compromised, they wake up.
Cue relapse.
Lab work suggests that dapsone:
Has activity against slow-growing or stationary-phase bacterial cells.
It may penetrate biofilms better when used in combination protocols.
Can synergize with other antibiotics that hit different life stages of Borrelia or other microbes.
The idea isn’t that dapsone is magically “stronger.”
It targets a different vulnerability, more like cutting off the power to a building instead of just breaking windows.
Here’s the catch: in vitro isn’t in vivo.
Petri dishes don’t have immune systems, hormones, mold toxins, or trauma history.
They don’t have mitochondria to damage, red blood cells to oxidize, or refresh pathways to overload.
So while the persister theory is compelling, clinical reality is messier:
Some patients do see significant short-term improvements.
Others feel nothing.
A subset actually gets worse, sometimes severely.
That doesn’t mean the theory is false. It means dapsone lives in that uncomfortable zone of “promising but not a benefit, and absolutely not low-risk.”
You deserve your doctor to be transparent about that gray area instead of selling it as the answer.
Let’s talk about what many patients really care about:
“If I go through all this, does it actually last?”
Early reports and small case series on dapsone-based protocols suggest something many of our patients also notice: short-term symptom relief can be real.
Fatigue may lighten.
Brain fog may lift.
Joint pain or neuropathy may settle down.
This can feel absolutely life-giving after years of struggle.
But when you zoom out to a one-year follow-up or longer, the picture isn’t so simple.
Some patients hold their gains.
A significant portion relapses, sometimes partially, sometimes almost entirely back to baseline.
Why the mismatch between early wins and long-term reality?
It helps to think of dapsone as a sharp tool against one piece of the puzzle rather than a house remodel. It might cut down bacterial load, including persisters, but if the foundation is still cracked, problems return.
Several significant reasons remission often fades after any heavy antibiotic course, dapsone included:
Root causes weren’t fully addressed.
If your immune system is still suppressed, your sleep is broken, you’re inflamed from mold or gut dysfunction, and your stress response is on fire, infections can reassert themselves.
Coinfections were missed or undertreated.
Bartonella, Babesia, Mycoplasma, parasites, viruses… they’re common in complex Lyme cases. If you hit Borrelia hard but ignore coinfections, symptoms can linger or morph, and it might seem like dapsone “stopped working.”
Biofilms and toxin burden remain.
Biofilms can shelter mixed microbial communities. Killing more bugs without supporting refresh, drainage, and binders sometimes means you just stir the swamp.
Antibiotics don’t reverse immune and inflammatory damage.
Antibiotics don’t automatically fix mitochondrial damage, autoimmunity, or neuroinflammation. Those require targeted repair work, nutrients, lifestyle, nervous system regulation, hormone support, and sometimes low-dose immunomodulators.
Tissue damage takes longer than a drug cycle to heal.
Nerves, joints, fascia, and brain tissue repair at their own pace. Expecting a three- or six-month antibiotic phase to undo years of wear and tear is… optimistic.
At My Lyme Doc, when we see someone who’s done dapsone and then relapsed, our first question is rarely, “Do you need more dapsone?”
It’s usually, “What did we miss underneath?” Mold exposure? Hidden dental infections? Mast cell activation? Trauma drives a frozen nervous system that can’t move into healing.
If nobody explores those layers, remission tends to be temporary, no matter how strong the antibiotic.
Here’s where things get real.
Dapsone is not a “try it and see” supplement.
It’s a serious medication with well-known risks that absolutely demand close medical supervision and lab monitoring.
Not everyone experiences all of these, but you’ll see patterns in stories:
Nausea, abdominal discomfort
Headaches
Fatigue that feels different from “usual Lyme tired.”
Insomnia or wired-but-exhausted states
Skin rashes
Some of these can overlap with Herxheimer reactions (die-off), so it can be hard to tell whether you’re herxing or being harmed.
That’s where careful tracking and a doctor who actually listens become essential.
Dapsone can cause significant, sometimes dangerous, problems, including:
Hemolytic anemia – destruction of red blood cells, which can leave you breathless, weak, and lightheaded.
Methemoglobinemia – a condition where your blood can’t carry oxygen well, sometimes leading to blue lips, shortness of breath, chest discomfort, and profound fatigue.
Severe skin reactions – including Stevens–Johnson syndrome, which is a medical emergency.
Liver stress and elevated liver enzymes.
Certain people are at higher risk, especially those with G6PD deficiency or other underlying blood/oxidative issues. You should be screened before even considering this medication.
Any responsible dapsone protocol should include:
Baseline and ongoing CBC (complete blood count)
Liver function tests
Screening for G6PD deficiency
Regular check-ins for symptoms of shortness of breath, chest pain, sudden weakness, confusion, or new rashes
If you’re on dapsone and no one is doing labs, that’s a huge red flag.
If you’ve already tried treatments like doxycycline, cefuroxime, rifampin, or azithromycin, you might be wondering how dapsone stacks up.
Here’s the big picture, not a ranking chart.
Doxycycline / Amoxicillin / Cefuroxime
These tend to focus on more actively dividing forms of Borrelia. They’re often part of early Lyme or initial chronic Lyme treatment. Side effects are common but usually more predictable.
Rifampin / Rifabutin
Often used when Bartonella or other intracellular bacteria are suspected. They come with their own risks (liver stress, drug interactions) but don’t typically carry the same hemolytic risk as dapsone.
Macrolides (Azithromycin, Clarithromycin)
Sometimes combined with others for synergy. It can impact heart rhythm in some people and gut flora in many.
Dapsone
Used more selectively, typically in patients with long-standing, treatment-resistant symptoms and a strong suspicion of persister involvement. Risk profile is sharper: blood, oxygen-carrying capacity, and severe skin reactions are front and center.
There is no single best drug for Lyme.
Anyone who tells you otherwise either hasn’t seen enough real patients or is selling you something.
What matters more is:
Your infection mix (Lyme + which coinfections?)
Your current resilience (gut, liver, mitochondria, nervous system)
Past treatment history and reactions
Genetics such as G6PD status and other polymorphisms
In our practice, we think of medications like dapsone as specialized tools, not default settings. They can be powerful in the proper context, but they’re a poor substitute for a truly comprehensive plan.
Many integrative and functional protocols are used:
Herbal antimicrobials like Japanese knotweed, cat’s claw, andrographis, cryptolepis, sida, and houttuynia.
Essential oils or their constituents in carefully dosed, internal or topical forms (under professional guidance).
Biofilm disruptors, such as specific enzymes or botanicals.
These can sometimes target multiple organisms at once, Lyme, coinfections, and gut dysbiosis, while being gentler on your microbiome.
Not “better” across the board. Just different trade-offs.
This is the boring part that actually changes lives.
Address mold exposure in your home or workplace (huge in our Colorado and nationwide telehealth patients).
Support liver and bile flow with nutrients like phosphatidylcholine, bitters, and sometimes binders for toxins.
Rebuild mitochondria with nutrients like CoQ10, L-carnitine, B vitamins, magnesium, and good fats.
Nourish the nervous system with vagus nerve work, breath practices, trauma-informed therapy, and actual rest.
When these supports are in place, even mild antimicrobial strategies often perform much better.
So where, in a thoughtful, integrative, Lyme-literate framework, does dapsone potentially fit?
Dapsone is more likely to be considered when:
You’ve had documented Lyme and/or coinfections for a long time.
You’ve already done multiple well-designed antibiotic and/or herbal protocols with partial but incomplete responses.
Your clinician has strong reason to suspect persister-heavy or biofilm-protected infections.
You’re medically screened (including G6PD) and able to do close lab monitoring.
It should not be the first thing tried because a TikTok said it “finally killed Lyme.”
If dapsone is on the table, you want a provider who:
Understands functional medicine and chronic infections, not just acute Lyme.
Will design a protocol that supports your gut, liver, mitochondria, and refresh while on therapy.
Has an exit strategy, which is what happens after the course finishes, so you’re not left hanging.
This is precisely the kind of scenario we see at My Lyme Doc.
Sometimes, after a whole intake and testing, the conclusion is, “Yes, dapsone could be appropriate later, but first we need to handle mold, mast cell activation, or hormone collapse.”
Other times, we look at the risks and your history and say, “There are better starting points for you.”
The key: you shouldn’t feel pushed or shamed into or out of this medication. You should feel like an informed partner in a nuanced decision.
If you’re considering dapsone, bring these to your next appointment:
Why do you think I, specifically, might benefit from this?
What alternatives are we ruling out, and why?
What labs will we run before starting and how often during treatment?
How will we tell the difference between a Herxheimer reaction and real toxicity?
What’s our plan to support my gut, liver, and mitochondria while I’m on this?
What does the plan look like after dapsone, if we use it?
If those questions make your provider defensive or annoyed, that’s data too.
If you’ve read this far, you’re clearly not looking for quick, shallow answers. Standing at this crossroads right now, feeling torn between fear of side effects and fear of wasting more time? Start here:
Get eyes on your whole picture.
Infections, yes, but also mold, toxins, hormones, sleep, trauma, and nervous system health.
Ask hard questions.
Any provider recommending dapsone should be able to explain why you are a candidate, how they’ll monitor you, and what the long game looks like.
Protect your hope, not just your labs.
You deserve a plan that supports your brain, mood, and body, not just a protocol that looks impressive on paper.
At My Lyme Doc, this is the lens we bring to every complex case, Lyme, mold, coinfections, and the long list of symptoms that come with them. Whether you ever touch dapsone or not, you’re not “too complex” or “too far gone” to deserve thoughtful, integrative, science-informed care.
If your gut is saying, “I need someone to help me sort this out,” listen to it.
That inner researcher in you has carried you this far.
With the proper guidance, it doesn’t have to carry the whole load alone.
Dapsone is an older sulfa-type antibiotic originally approved for leprosy and certain autoimmune skin conditions. Some Lyme-literate doctors now use it off-label for chronic Lyme disease because lab studies suggest it may help target “persister” or dormant forms of Borrelia when combined with other medications and a broader treatment plan.
Some patients report short-term improvements in fatigue, brain fog, and pain on dapsone-based protocols, but relapse at 6–12 months is not uncommon. Outcomes are often temporary if deeper issues—like mold exposure, coinfections, immune dysregulation, and mitochondrial damage—aren’t addressed alongside antimicrobial treatment and comprehensive support.
Dapsone can cause nausea, headaches, rashes, and unusual fatigue, but its most serious risks include hemolytic anemia, methemoglobinemia (reduced oxygen-carrying capacity), liver stress, and rare severe skin reactions like Stevens–Johnson syndrome. Because of these dangers, patients need G6PD screening, regular bloodwork, and close supervision by a qualified clinician.
Yes. Many integrative clinicians use combinations of other antibiotics, herbal antimicrobials (such as Japanese knotweed, cat’s claw, and cryptolepis), biofilm disruptors, detox and drainage support, mold remediation, mitochondrial nutrients, and nervous system therapies. These approaches often aim to reduce microbial load while strengthening immune, gut, and detox systems to support more durable recovery.
Dapsone is usually considered only in select, treatment-experienced patients with long-standing Lyme and suspected persister or biofilm-heavy infections. A Lyme-literate provider should review your full history, prior treatments, coinfections, mold exposure, G6PD status, lab results, and overall resilience, then discuss risks, monitoring plans, and alternatives before deciding if it’s appropriate.
Horowitz, R. I., Murali, K., Gaur, G., Freeman, P. R., & Sapi, E. (2020). Effect of dapsone alone and in combination with intracellular antibiotics against the biofilm form of Borrelia burgdorferi. BMC Research Notes, 13(1), 455. https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-020-05298-6
Feng, J., Li, T., Yee, R., Yuan, Y., Bai, C., Cai, M., … & Zhang, Y. (2017). Activity of sulfa drugs and their combinations against stationary phase Borrelia burgdorferi in vitro. Antibiotics, 6(1), 10. https://www.mdpi.com/2079-6382/6/1/10
Horowitz, R. I., & Freeman, P. R. (2022). Comparison of the efficacy of longer versus shorter pulsed high dose dapsone combination therapy in the treatment of chronic Lyme disease/post-treatment Lyme disease syndrome with Bartonellosis and associated coinfections. Microorganisms, 11(9), 2301. https://www.mdpi.com/2076-2607/11/9/2301
Haddad, F., & Phelps, S. J. (2015). Dapsone induced hypersensitivity syndrome and hematologic toxicities. International Journal of Nutrition, Pharmacology, Neurological Diseases. https://journals.lww.com/ijnp/fulltext/2015/05030/dapsone_induced_hypersensitivity_syndrome%2C.6.aspx
Hines, K., Temesvary, S., & Glaser, S. (2022). Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria. Case Reports in Medicine. https://pubmed.ncbi.nlm.nih.gov/36444994/
We have helped thousands of
people restore their health
and quality of life by diagnosing
and treating their Lyme Disease.
“Dr. Mueller’s approach to medicine is refreshing! There is only so much you can do with western medicine and in my life I was needing a new approach. By addressing the whole body, nutritional diet factors, environmental factors, blood work, and incorporating ideas I had not previously known, I was able to break through with my conditions. I am not only experiencing less pain in my life, but through the process of healing guided by Dr. Diane Mueller, I am now happy to say I have more consciousness surrounding how I eat, what to eat and when things are appropriate. Living by example Dr. Mueller has a vibrancy that makes you want to learn and know more about your body and overall health. I highly recommend her to anyone looking for new answers, a new approach to health, or in need of freedom from pain and limitations.”
-Storie S.
Kihei, HI
